Healthcare Sector

AZN

Market Tracker

$194.63
-2.89
(-1.46%)
5:20 am
Next Earnings: (est.) n/a
  • AZN (Selected)

    AstraZeneca PLC

AZN Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

AZN Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

AZN Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

AZN Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

AZN Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

AZN Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
06/17/2027 CALL $190.00 19 +16 +533.33%
06/17/2027 PUT $140.00 15 +15
03/20/2026 PUT $185.00 88 +12 +15.79%
03/20/2026 PUT $180.00 18 +10 +125.00%
03/20/2026 PUT $190.00 71 +8 +12.70%
01/21/2028 CALL $110.00 266 +8 +3.10%
04/17/2026 PUT $97.50 56 -9 -13.85%
03/20/2026 PUT $110.00 5 -15 -75.00%
04/17/2026 PUT $87.50 473 -19 -3.86%
04/17/2026 PUT $230.00 2 -23 -92.00%
03/20/2026 PUT $115.00 0 -68 -100.00%
04/17/2026 PUT $115.00 2 -89 -97.80%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

AZN Major Holders

Name Pct Held Shares Total
Washington Mutual Investors Fund 1.04% 27.18M 1.81B
Vanguard/Primecap Fund 0.99% 25.87M 1.72B
Vanguard/Wellington Fund Inc. 0.73% 19.18M 1.28B
American Mutual Fund Inc 0.33% 8.7M 578.3M
Price (T.Rowe) Health Sciences Fund 0.30% 8M 531.71M
Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF 0.30% 7.93M 526.89M
Vanguard Fenway Funds-Equity Income Fund 0.27% 7.11M 472.77M
Price (T.Rowe) Value Fund 0.22% 5.86M 389.5M
Vanguard Fenway Fds-Primecap Core Fund 0.21% 5.63M 374.17M
Vanguard/Wellesley Income Fund 0.20% 5.28M 351.09M

AZN News

  • Cytokines Market Global Forecast 2026-2032: Precise Treatments, Strategic Partnerships, and Supply Chain Resilience Fueling the $95+ Billion Market

    03/05 05:44 am

    GlobeNewswire Inc.

    Read more
  • CDT Positions for Transformational Growth

    03/04 09:30 am

    Benzinga

    Read more
  • GLP-1 Receptor Agonist Business Analysis Report 2026: Market to Reach $137.4 Billion by 2030 - Clinical Trials Exploring GLP-1 Role in NAFLD and NASH Unlock Future Opportunities

    03/04 06:48 am

    GlobeNewswire Inc.

    Read more
  • Acute Ischemic Stroke Market Poised for Expansion During the Forecast Period (2026–2036) as Innovative Treatment Modalities Gain Momentum | DelveInsight

    03/02 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Antibiotics Market - 4.07% CAGR Forecast for 2026-2031 as Antimicrobial Innovation Strengthens Demand, Says Mordor Intelligence

    03/02 05:59 am

    GlobeNewswire Inc.

    Read more
  • PatentVest Releases New Report on The Oral Small-Molecule GLP-1 Patent Race

    02/26 02:35 pm

    GlobeNewswire Inc.

    Read more
  • FDA Approval For AbbVie/AstraZeneca's Combination Treatment Could Set New Standard For Slow Growing Blood Cancer

    02/20 09:02 am

    Benzinga

    Read more
  • Glucagon-like Peptide 1 (GLP-1) Market Report 2026-2035: Market to Reach $33.26 Billion by 2030 - Oral Formulations and Long-Acting Peptides Accelerate Next-Gen Obesity and Diabetes Therapies

    02/20 06:53 am

    GlobeNewswire Inc.

    Read more
  • CTLA-4 Inhibitors Competitive Landscape Research Report 2026: Comprehensive Insights About 40+ Companies and 50+ Drugs by Product Type, Stage, Route of Administration, and Molecule Type

    02/18 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Turner Syndrome Market Size to Reach USD 3.67 Billion by 2033, Fueled by Early Diagnosis Advances and Rising Awareness of Rare Chromosomal Disorders – SNS Insider

    02/18 06:55 am

    GlobeNewswire Inc.

    Read more
  • Uterine Fibroid Market Size to Reach USD 9.43 Billion by 2033 with 7.63% CAGR – SNS Insider

    02/16 09:00 am

    GlobeNewswire Inc.

    Read more
  • NIH Stops Johnson & Johnson's Blood Thinner Drug Arm In Stroke Trial After Safety Review (UPDATED)

    02/12 03:55 pm

    Benzinga

    Read more
  • AstraZeneca Cancer Portfolio Dominates Sales With Massive Double Digit Growth

    02/10 01:32 pm

    Benzinga

    Read more
  • Anti-Obesity Drugs Market to Reach US$195.99 Billion by 2036 as GLP-1 Therapies Drive a Structural Shift in Weight Management

    02/06 06:00 am

    GlobeNewswire Inc.

    Read more
  • This Global ETF Could Help Protect You From the "Sell America" Trade

    02/05 06:07 am

    The Motley Fool

    Read more
  • Obesity Treatment Market Size to Reach USD 75.69 Billion by 2033 as the Treatment Offers a Comprehensive Evaluation of Therapeutic Developments Globally

    02/05 05:00 am

    GlobeNewswire Inc.

    Read more
  • Human Vaccines Market Size to Reach USD 62.45 Billion by 2033, Driven by Expanding Immunization Programs – SNS Insider

    02/05 04:57 am

    GlobeNewswire Inc.

    Read more
  • AstraZeneca Responds With Data After FDA Delays Lupus Drug Shot

    02/03 07:55 am

    Benzinga

    Read more
  • Targeted Cancer Therapy Market to Reach US$ 175.48 Billion by 2035 Driven by Precision Oncology Adoption, ADC Innovation, and Regulatory Productivity Says Astute Analytica

    02/03 02:56 am

    GlobeNewswire Inc.

    Read more
  • AstraZeneca Expands Weight Loss Push With Eight-Program China Collaboration

    01/30 08:09 am

    Benzinga

    Read more
  • AstraZeneca Bets Big On China With Massive $15 Billion Investment

    01/29 12:51 pm

    Benzinga

    Read more
  • Atopic Dermatitis Market to Reach USD 12.97 Billion by 2034, Growing at 7.75% CAGR

    01/27 11:00 am

    GlobeNewswire Inc.

    Read more
  • Looking for Growth Opportunities Outside the U.S. Market? This International ETF Soared Past the S&P 500 Last Year

    01/23 08:32 am

    The Motley Fool

    Read more
  • Is This Dividend King Stock a Buy After a Major Development?

    01/21 10:30 pm

    The Motley Fool

    Read more
  • High Potency APIs Market Size to Reach USD 58.68 Billion by 2033, Driven by the Increasing Demand for Targeted and Oncology Therapies – SNS Insider

    01/21 12:00 pm

    GlobeNewswire Inc.

    Read more
  • AstraZeneca To Delist ADRs From Nasdaq By January, Eyes Broader Investor Reach

    01/20 12:47 pm

    Benzinga

    Read more
  • Bioconjugation Market Size to Hit USD 14.51 Billion by 2033, Driven by the Increasing Demand for Targeted Therapeutics – SNS Insider

    01/19 12:00 pm

    GlobeNewswire Inc.

    Read more
  • AbelZeta Announces Remaining China Rights to GPC3 Armored CAR-T Therapy to be Acquired by AstraZeneca

    01/18 08:30 pm

    Benzinga

    Read more
  • The Newest Stock in the Nasdaq-100 Soared 549,000% Since Its IPO, and It's Still a Buy Right Now, According to Wall Street (Hint: Not Strictly a Tech Company)

    01/15 04:02 am

    The Motley Fool

    Read more
  • Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference

    01/14 09:25 pm

    GlobeNewswire Inc.

    Read more
  • Generalized Myasthenia Gravis Market Outlook Shows Strong Momentum During the Forecast Period (2025–2034) Driven by Novel Immunotherapies | DelveInsight

    01/14 02:00 pm

    GlobeNewswire Inc.

    Read more
  • HUTCHMED Highlights Publication of Phase III SACHI Results in The Lancet

    01/14 12:00 am

    GlobeNewswire Inc.

    Read more
  • 1 Quantum Computing Stock to Buy that Could Soar in 2026

    01/13 03:16 pm

    The Motley Fool

    Read more
  • Systemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics – Approvals of BENLYSTA and SAPHNELO, Plus a Strong Pipeline | DelveInsight

    01/13 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Pharmacy XD Launches Nationally Licensed Direct-to-Patient Mail Order Pharmacy and Distribution Platform - Headquartered in Florida's Fastest-Growing Healthcare Corridor

    01/08 05:30 pm

    Benzinga

    Read more
  • AstraZeneca's Self-Injectable Lupus Drug Shines In Late-Stage Trial

    01/06 07:43 am

    Benzinga

    Read more
  • G-Protein Coupled Receptors (GPCRs) Market Size to Hit USD 6.04 Billion by 2032, Growing at a CAGR of 5.59% - SNS Insider

    01/05 11:00 am

    GlobeNewswire Inc.

    Read more
  • Invest Outside the U.S. With These Top International ETFs

    12/31 03:20 pm

    The Motley Fool

    Read more
  • AstraZeneca's Lung Cancer Combo Falls Short In Phase 3 Trial

    12/22 01:19 pm

    Benzinga

    Read more
  • GSK Expands Use Of Urinary Tract Infection Drug For Gonorrhoea Patients

    12/12 12:12 pm

    Benzinga

    Read more
  • Gestational Diabetes Market to Reach USD 22.58 Billion by 2034, Driven by Rising Awareness and Rapid Innovations

    12/11 11:00 am

    GlobeNewswire Inc.

    Read more
  • Drugmakers Briefed As Vaccine Skeptics Like RFK Jr. Probe RSV Therapy Risks

    12/09 12:30 pm

    Benzinga

    Read more
  • AstraZeneca, GSK Among Executives Asked To Help Redesign UK Pricing Rules-Report

    12/03 01:24 pm

    Benzinga

    Read more
  • AstraZeneca's Hard To Control Hypertension Drug Advances, With FDA Decision Expected In 2026

    12/03 11:27 am

    Benzinga

    Read more
  • Seasonal Vaccines Market Accelerating Growth and Rising Opportunities Through 2035

    12/03 11:00 am

    GlobeNewswire Inc.

    Read more
  • Vaccine Development Company Landscape Report 2025: Recent Expansions, Partnerships and Collaborations, Big Pharma Initiatives and Cost Price Analysis

    12/02 05:37 am

    GlobeNewswire Inc.

    Read more
  • Geriatric Care Services Market is expected to generate a revenue of USD 2.03 Billion by 2032, Globally, at 7.98% CAGR: Verified Market Research®

    11/27 11:50 pm

    GlobeNewswire Inc.

    Read more
  • HER2-positive Gastric Cancer Clinical Trial Pipeline: Insights into a Growing Landscape with 20+ Companies Advancing Novel Treatments| DelveInsight

    11/27 02:00 pm

    GlobeNewswire Inc.

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: